BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND IKZF1, LyF-1, 10320, ENSG00000185811, Q13422, Hs_54452, hIk-1, ZNFN1A1, IKAROS AND Prognosis
120 results:

  • 1. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
    Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
    Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic Leukemia: Focus on the Genes Involved.
    Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Pre- and Postnatal Exposures to Tobacco Smoking and Survival of Childhood Acute Lymphoblastic and Myeloid Leukemias in California, United States.
    Metayer C; Morimoto LM; Kang AY; Sanchez Alvarez J; Winestone LE
    Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):117-125. PubMed ID: 37921440
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Toblerone: detecting exon deletion events in cancer using RNA-seq.
    Lonsdale A; Halman A; Brown L; Kosasih H; Ekert P; Oshlack A
    F1000Res; 2023; 12():130. PubMed ID: 37767021
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Genes of Predisposition to Childhood Beta-Cell Acute Lymphoblastic Leukemia in the Kazakh Population.
    Svyatova G; Boranbayeva R; Berezina G; Manzhuova L; Murtazaliyeva A
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2653-2666. PubMed ID: 37642051
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Genetic alterations and MRD refine risk assessment for KMT2A-rearranged B-cell precursor ALL in adults: a GRAALL study.
    Kim R; Bergugnat H; Pastoret C; Pasquier F; Raffoux E; Larcher L; Passet M; Grardel N; Delabesse E; Kubetzko S; Caye-Eude A; Meyer C; Marschalek R; Lafage-Pochitaloff M; Thiebaut-Bertrand A; Balsat M; Escoffre-Barbe M; Blum S; Baumann M; Banos A; Straetmans N; Gallego-Hernanz MP; Chalandon Y; Graux C; Soulier J; Leguay T; Hunault M; Huguet F; Lhéritier V; Dombret H; Boissel N; Clappier E
    Blood; 2023 Nov; 142(21):1806-1817. PubMed ID: 37595275
    [TBL] [Abstract] [Full Text] [Related]  

  • 7.
    Al-Zayan NR; Ashour MJ; Abuwarda HN; Sharif FA
    Pediatr Hematol Oncol; 2024; 41(2):103-113. PubMed ID: 37578068
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors.
    Tsai HK; Gogakos T; Lip V; Tsai JM; Li YD; Fisch AS; Weiss J; Yang W; Grimmett L; DiToro D; Schaefer EJ; Lindsley RC; Tran TH; Caron M; Langlois S; Sinnett D; Pikman Y; Nardi V; Kim AS; Silverman LB; Harris MH
    J Mol Diagn; 2023 Sep; 25(9):665-681. PubMed ID: 37419244
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The prognostic impact of ikzf1 deletions and UKALL genetic classifiers in paediatric B-cell precursor acute lymphoblastic leukaemia treated according to NOPHO 2008 protocols.
    Öfverholm I; Rezayee F; Heyman M; Harila A; Arvidsson L; Schmiegelow K; Norén-Nyström U; Barbany G
    Br J Haematol; 2023 Jul; 202(2):384-392. PubMed ID: 37156607
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Prevalence and prognostic significance of ikzf1 deletion in paediatric acute lymphoblastic leukemia: A systematic review and meta-analysis.
    Srinivasan S; Ramanathan S; Kumar S; Peyam S; Radhakrishnan V
    Ann Hematol; 2023 Aug; 102(8):2165-2179. PubMed ID: 37154889
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The prognostic value of ikzf1
    Kicinski M; Arfeuille C; Grardel N; Bakkus M; Caye-Eude A; Plat G; Ferster A; Uyttebroeck A; De Moerloose B; Rohrlich P; Suciu S; Bertrand Y; Cavé H
    Pediatr Blood Cancer; 2023 Jun; 70(6):e30313. PubMed ID: 36971444
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Contributions of ARID5B, ikzf1, PIP4K2A, and GATA3 Gene Polymorphisms to Childhood Acute Lymphoblastic Leukemia in a Chinese Population.
    Liu X; Xiao M; Xing Z; Jiang H; Zhu C; Zhang X; Li W; Wang Z; Wu F; Chen Y
    J Pediatr Hematol Oncol; 2023 Apr; 45(3):123-129. PubMed ID: 36952466
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial.
    Schwab C; Cranston RE; Ryan SL; Butler E; Winterman E; Hawking Z; Bashton M; Enshaei A; Russell LJ; Kingsbury Z; Peden JF; Barretta E; Murray J; Gibson J; Hinchliffe AC; Bain R; Vora A; Bentley DR; Ross MT; Moorman AV; Harrison CJ
    Leukemia; 2023 Mar; 37(3):529-538. PubMed ID: 36550215
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation overcome the poor prognosis of patients with ikzf1plus CD20-a very high-risk subtype in B-cell acute lymphoblastic leukemia.
    Tang B; Cai Z; Wang Z; Lin D; He X; Li Q; Liang X; Huang K; Zhou X; Lin R; Xu N; Fan Z; Huang F; Sun J; Liu X; Liu Q; Zhou H
    Bone Marrow Transplant; 2022 Dec; 57(12):1751-1757. PubMed ID: 36056210
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120.
    Fazio G; Bresolin S; Silvestri D; Quadri M; Saitta C; Vendramini E; Buldini B; Palmi C; Bardini M; Grioni A; Rigamonti S; Galbiati M; Mecca S; Savino AM; Peloso A; Tu JW; Bhatia S; Borkhardt A; Micalizzi C; Lo Nigro L; Locatelli F; Conter V; Rizzari C; Valsecchi MG; Te Kronnie G; Biondi A; Cazzaniga G
    EBioMedicine; 2022 Sep; 83():104224. PubMed ID: 35985167
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Feasibility and clinical utility of comprehensive genomic profiling of hematological malignancies.
    Fukuhara S; Oshikawa-Kumade Y; Kogure Y; Shingaki S; Kariyazono H; Kikukawa Y; Koya J; Saito Y; Tabata M; Yoshifuji K; Mizuno K; Miyagi-Maeshima A; Matsushita H; Sugiyama M; Ogawa C; Inamoto Y; Fukuda T; Sugano M; Yamauchi N; Minami Y; Hirata M; Yoshida T; Kohno T; Kohsaka S; Mano H; Shiraishi Y; Ogawa S; Izutsu K; Kataoka K
    Cancer Sci; 2022 Aug; 113(8):2763-2777. PubMed ID: 35579198
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Aberrant ikzf1 gene as relapse predictor in standard-risk pediatric patients with B-cell precursor acute lymphoblastic leukaemia.
    Vshyukova VS; Krasko OV; Yanchanka DA; Meleshko AN
    Int J Lab Hematol; 2022 Aug; 44(4):769-776. PubMed ID: 35505470
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Prognostic significance of ikzf1 gene deletions in patients with B-cell acute lymphoblastic leukemia].
    Tang BQ; Cai ZH; Lin DN; Wang ZX; Liang XJ; Fan ZP; Huang F; Liu QF; Zhou HS
    Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):235-240. PubMed ID: 35405782
    [No Abstract]    [Full Text] [Related]  

  • 19. CRLF2 overexpression defines an immature-like subgroup which is rescued through restoration of the PRC2 function in T-cell precursor acute lymphoblastic leukemia.
    Maciel ALT; Wolch K; Emerenciano M; Mansur MB
    Genes Chromosomes Cancer; 2022 Jul; 61(7):437-442. PubMed ID: 35253299
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Genomic heterogeneity contributed to different prognosis between adult and pediatric acute lymphoblastic.
    Chen Y; Zheng Y; Hong Y; Wen J; Li J; Huang Y; Chen Y; Zheng X; Yang T; Xu Y; Zheng J; Hu J
    J Leukoc Biol; 2022 Sep; 112(3):513-522. PubMed ID: 35172382
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.